Indication
Myocardial infarction with Q wave
1 clinical trial
2 products
Clinical trial
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary SyndromeStatus: Completed, Estimated PCD: 2023-08-01
Product
RosuvastatinProduct
Atorvastatin